# US 2013/0157361 A1 · Catalytic domains from lysyl oxidase and loxl2

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157361 A1
- Document ID: US20130157361A1
- Status: Published application
- Kind: A1
- Application number: 13/776,578
- Filed: 2013-02-25
- Published: 2013-06-20
- Earliest claimed: 2009-08-21
- Assignees: Gilead Biologics, Inc.
- Inventors: Scott MCCAULEY; Victoria SMITH
- Web page: https://patentgrep.com/patent/US20130157361A1

## CPC

- C12N 9/0022: {with oxygen as acceptor (1.4.3)}
- C12Y 104/03013: Protein-lysine 6-oxidase (1.4.3.13), i.e. lysyl-oxidase
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Disclosed herein are amino acid sequences, and encoding nucleotide sequences, of isolated catalytic domains of the LOX and LOXL2 proteins from human and mouse. Methods for the preparation and use of these isolated catalytic domains are also provided.

## Claims

### Claim 1

An isolated polynucleotide, comprising:
a nucleotide sequence encoding a polypeptide comprising a catalytic domain of a human or murine LOX or LOXL2 protein, wherein:
the polypeptide comprises the amino acid sequence selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 1 without the initial GL residues, SEQ ID NO: 3 or SEQ ID NO: 3 without the initial TA residues, SEQ ID NO:5, SEQ ID NO:5 without the initial GL residues, and SEQ ID NO:7, SEQ ID NO:7 without the initial TA residues; and
the polypeptide does not contain sequences from the human or murine LOX or LOXL2 protein outside its catalytic domain.

### Claim 2 (depends on 1)

The isolated polynucleotide of claim 1, wherein the polynucleotide is a cDNA.

### Claim 3 (depends on 1)

The isolated polynucleotide of claim 1, wherein the polynucleotide encoding the polypeptide does not contain introns.

### Claim 4 (depends on 1)

The polynucleotide of claim 1, wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO:1.

### Claim 5 (depends on 1)

The polynucleotide of claim 1, wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO:3.

### Claim 6 (depends on 1)

The polynucleotide of claim 1, wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO:5.

### Claim 7 (depends on 1)

The polynucleotide of claim 1, wherein the polypeptide further comprising a signal sequence, an epitope tag and a purification tag.

### Claim 8 (depends on 7)

The polynucleotide of claim 7, wherein the signal sequence is an immunoglobulin kappa signal sequence.

### Claim 9 (depends on 7)

The polynucleotide of claim 7, wherein the epitope tag is myc tag.

### Claim 10 (depends on 7)

The polynucleotide of claim 7, wherein the purification tag is a His6 tag.

### Claim 11 (depends on 1)

An expression vector comprising the polynucleotide of claim 1.

### Claim 12 (depends on 11)

A recombinant host cell comprising the expression vector of claim 11.
